BLOCKsyncop is developing the Neural Blockade Monitor, a non-invasive device that provides real-time, objective measurements of neural block effectiveness during anesthesia. This technology addresses the lack of clinical tools to monitor local anesthetic efficacy, thereby reducing the risk of failed blocks and optimizing patient pain management.
Funding
$275K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing the effectiveness of neural blocks during anesthesia rely on subjective clinical evaluations, leading to potential inaccuracies in determining the adequacy of pain management. The absence of objective monitoring tools increases the risk of failed blocks, anesthetic toxicity, and suboptimal pain control.
Solution
BLOCKsyncop is developing the Neural Blockade Monitor (NBM), a non-invasive device designed to provide real-time, quantitative measurements of neural blockade effectiveness. The NBM aims to give anesthesiologists an objective assessment of local anesthetic efficacy, allowing for optimized drug delivery and improved patient outcomes. By offering a direct measurement of the block's impact, the NBM can help reduce the incidence of failed blocks, minimize the risk of anesthetic toxicity, and tailor analgesic administration to individual patient needs. The device integrates biomedical and systems engineering principles to deliver a practical clinical monitoring solution.
Target Audience
The primary target audience includes anesthesiologists and pain management specialists who require objective monitoring of neural blockade effectiveness during surgical procedures and pain management interventions.
Features
- Non-invasive sensor technology for real-time monitoring of neural blockade
- Objective, quantitative measurements of local anesthetic effectiveness
- Data display providing clinicians with immediate feedback on block efficacy
- Designed to reduce the risk of failed neural blocks
- Aims to optimize analgesic requirements and minimize anesthetic toxicity